Logo

Qiagen QCI Precision Insights

Jan 27, 2020

Qiagen has launched Qiagen QCI Precision Insights in Europe. QCI Precision Insights is a clinical interpretation service provided by a team of molecular biologists and oncologists who translate patient-specific molecular data into clinical insights and therapeutic options. The new offering includes European Society for Medical Oncology (ESMO) guidelines and the European Medicines Agency (EMA)-approved oncology drugs catalog. Qiagen said that the service enables molecular pathologists and oncologists in Europe to confidently match complex genomic test data to relevant, geographically matched treatment options in minutes for evidence-based, individualized treatment recommendations.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.